MeiraGTx Holdings (MGTX) EBITDA Margin (2019 - 2025)
MeiraGTx Holdings (MGTX) recorded EBITDA Margin of 39.26% in Q4 2025, up 172.12 percentage points from -132.86% a year earlier and up 10501.70 percentage points from the prior quarter.
MeiraGTx Holdings (MGTX) EBITDA Margin (2019 - 2025) Analysis & Trends
For FY2025, MeiraGTx Holdings reported EBITDA Margin of -114.79%, up 340.11 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of +260.35 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -454.89% in FY2024 (+424.97 pp), -879.87% in FY2023 (-203.79 pp), -676.08% in FY2022 (-503.98 pp) and -172.10% in FY2021 (+203.03 pp).
- The Q4 2025 figure is the highest quarterly EBITDA Margin in data going back to Q1 2019.
- On a year-over-year basis, EBITDA Margin rose in five of the last eight quarters, with an average year-over-year change of -1180.24 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 14010.80 percentage points in Q2 2025, against a drop of 14416.53 percentage points in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -10462.44% (Q3 2025), -1127.15% (Q2 2025) and -1999.74% (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | MeiraGTx Holdings | 1.05 Bn | 792.42 Mn | 314.27 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 39.26% |
| Sep 30, 2025 | -10,462.44% |
| Jun 30, 2025 | -1,127.15% |
| Mar 31, 2025 | -1,999.74% |
| Dec 31, 2024 | -132.86% |
| Sep 30, 2024 | -337.14% |
| Jun 30, 2024 | -15,137.94% |
| Mar 31, 2024 | -6,240.60% |
| Dec 31, 2023 | -1,953.04% |
| Sep 30, 2023 | -573.84% |
| Jun 30, 2023 | -721.41% |
| Mar 31, 2023 | -859.87% |
| Sep 30, 2022 | -431.48% |
| Jun 30, 2022 | -201.44% |
| Mar 31, 2022 | -472.50% |
| Dec 31, 2021 | -26.75% |
| Sep 30, 2021 | -295.26% |
| Jun 30, 2021 | -360.97% |
| Mar 31, 2021 | -441.22% |
| Dec 31, 2020 | -313.28% |
MeiraGTx Holdings EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MGTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "MGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();